Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The cellular activity of several regulatory and signal transduction proteins, which depend on the Hsp90 molecular chaperone for folding, is markedly decreased by geldanamycin and by radicicol (monorden). We now show that these unrelated compounds both bind to the N-terminal ATP/ADP-binding domain of Hsp90, with radicicol displaying nanomolar affinity, and both inhibit the inherent ATPase activity of Hsp90 which is essential for its function in vivo. Crystal structure determinations of Hsp90 N-terminal domain complexes with geldanamycin and radicicol identify key aspects of their nucleotide mimicry and suggest a rational basis for the design of novel antichaperone drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Self-citationDynamic activation of endothelial nitric oxide synthase by Hsp90
García-Cardeña, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo
Panaretou, B., Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4829 · Cited by 735
Self-citationGrenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H.-J., Schulte, T. W., Sausville, E., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23843 · Cited by 569
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Joab, I., Radanyi, C., Renoir, M., Buchou, T., Catelli, M.-G., Binart, N., Mester, J., & Baulieu, E.-E. (1984) · Nature · doi:10.1038/308850a0 · Cited by 434
Research works printed but not linked: 15
- Kwon H. J., 1992, Biosci. Biotechnol. Biochem., 56, 539
- Zhao J. F., 1995, Oncogene, 11, 173
- Kwon H. J., 1995, J. Biochem., 118, 228
- Fukazawa H., 1991, Biochem. Pharmacol., 42, 1671
- Smith D. F., 1995, Mol. Cell. Biol., 15, 6812
- Whitesell L., 1996, Endocrinology, 10, 712
- Ali J. A., 1993, Biochemistry, 32, 2724
- Cutler H. G., 1987, Agric. Biol. Chem., 51, 3338
- Schnur R. C., 1995, J. Med. Chem., 38, 3820
- Schnur R. C., 1995, J. Med. Chem., 38, 3812
- Hartmann F., 1997, Int. J. Cancer, 70, 229, 10.1002/(SICI)1097-0215(19970117)70:2<221::AID-IJC14>3.0.CO;2-L · doi:10.1002/(sici)1097-0215(19970117)70:2<221::aid-ijc14>3.0.co;2-l
- Dai K., 1996, J. Biol. Chem., 271, 22034
- Whitesell L., 1992, Cancer Res., 52, 1728
- Prodromou C., 1996, PROTEINS: Struct. Funct. Genet., 25, 522
- Merrit E. A., 1994, Acta Crystallogr., 50, 873
Cited by
Items 401–500 of 1,000
Parkinson's disease, proteins, and prions: Milestones
Olanow, C. W., & McNaught, K. S. P. (2011) · Movement Disorders · doi:10.1002/mds.23767 · Cited by 55
Sepehrimanesh, M., Kazemipour, N., Saeb, M., Nazıfı, S., & Davis, D. L. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-8882-z · Cited by 45
Inhibition of HSP90 with Pochoximes: SAR and Structure‐Based Insights
Barluenga, S., Fontaine, J., Wang, C., Aouadi, K., Chen, R., Beebe, K. E., Neckers, L., & Winssinger, N. (2009) · ChemBioChem · doi:10.1002/cbic.200900494 · Cited by 47
Nakatani, H., Kobayashi, M., Jin, T., Taguchi, T., Sugimoto, T., Nakano, T., Hamada, S., & Araki, K. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00018.x · Cited by 43
Structure-based design of 7-carbamate analogs of geldanamycin
Rastelli, G., Tian, Z., Wang, Z., Myles, D. C., & Liu, Y. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.013 · Cited by 42
The heat shock proteins: Their roles as multi-component machines for protein folding
Panaretou, B., & Zhai, C. (2008) · Fungal Biology Reviews · doi:10.1016/j.fbr.2009.04.002 · Cited by 50
Piaz, F. D., Malafronte, N., Romano, A., Gallotta, D., Belisario, M. A., Bifulco, G., Gualtieri, M., Sanogo, R., Tommasi, N. D., & Pisano, C. (2012) · Phytochemistry · doi:10.1016/j.phytochem.2011.12.002 · Cited by 42
Schroda, M., & Vallon, O. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-370873-1.00027-7 · Cited by 47
Concise Synthesis of Pochonin A, an HSP90 Inhibitor
Moulin, É., Barluenga, S., & Winssinger, N. (2005) · Organic Letters · doi:10.1021/ol052263+ · Cited by 42
Applications of total synthesis toward the discovery of clinically useful anticancer agents
Wilson, R. M., & Danishefsky, S. J. (2007) · Chemical Society Reviews · doi:10.1039/b611967k · Cited by 42
Zhu, F., & Pisetsky, D. S. (2001) · Infection and Immunity · doi:10.1128/iai.69.9.5546-5552.2001 · Cited by 48
Garnaud, C., García-Oliver, E., Wang, Y., Maubon, D., Bailly, S., Despinasse, Q., Champleboux, M., Govin, J., & Cornet, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01785-17 · Cited by 41
Heat shock proteins as targets in oncology
Órtiz, A. G., & Salcedo, J. M. (2010) · Clinical & Translational Oncology · doi:10.1007/s12094-010-0486-8 · Cited by 43
Liu, W., Vielhauer, G. A., Holzbeierlein, J. M., Zhao, H., Ghosh, S., Brown, D. R., Lee, E., & Blagg, B. S. J. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.097303 · Cited by 41
Harmicines − harmine and cinnamic acid hybrids as novel antiplasmodial hits
Perković, I., Raić‐Malić, S., Fontinha, D., Prudêncio, M., de Carvalho, L. P., Held, J., Tandarić, T., Vianello, R., Zorc, B., & Rajić, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111927 · Cited by 41
Biancatelli, R. M. L. C., Solopov, P. A., Gregory, B. W., & Catravas, J. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155286 · Cited by 43
Nonredundant functions of Mycobacterium tuberculosis chaperones promote survival under stress
Harnagel, A. P., Quezada, L. A. L., Park, S. W., Baranowski, C., Kieser, K. J., Jiang, X., Roberts, J., Vaubourgeix, J., Yang, A., Nelson, B., et al. (2020) · Molecular Microbiology · doi:10.1111/mmi.14615 · Cited by 43
Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol
Gadelle, D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki526 · Cited by 41
Structure‐Based and in silico Design of Hsp90 Inhibitors
Sgobba, M., & Rastelli, G. (2009) · ChemMedChem · doi:10.1002/cmdc.200900256 · Cited by 46
Diversity‐Oriented Synthesis of Pochonins and Biological Evaluation against a Panel of Kinases
Moulin, É., Barluenga, S., Totzke, F., & Winssinger, N. (2006) · Chemistry - A European Journal · doi:10.1002/chem.200600553 · Cited by 42
Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington’s Disease
Kim, S., & Kim, K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.1.36 · Cited by 43
Mutations that increase both Hsp90 ATPase activity in vitro and Hsp90 drug resistance in vivo
Zurawska, A. E., Urbański, J., Matulienė, J., Baraniak, J., Klejman, M. P., Filipek, S., Matulis, D., & Bieganowski, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.03.002 · Cited by 42
Natural resorcylic acid lactones: A chemical biology approach for anticancer activity
Kuttikrishnan, S., Prabhu, K. S., Sharie, A. H. A., Zu’bi, Y. O. A., Alali, F. Q., Oberlies, N. H., Ahmad, A., El‐Elimat, T., & Shahab Uddin, M. S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.001 · Cited by 42
Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents
Poje, G., de Carvalho, L. P., Held, J., Moita, D., Prudêncio, M., Perković, I., Tandarić, T., Vianello, R., & Rajić, Z. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114408 · Cited by 42
Zeke, T., MORRICE, N. A., Vázquez‐Martin, C., & Cohen, P. T. W. (2004) · Biochemical Journal · doi:10.1042/bj20040690 · Cited by 45
Stead, P., Latif, S., Blackaby, A. P., Sidebottom, P. J., Deakin, A. M., TAYLOR, N. L., Life, P. F., Spaull, J. R., Burrell, F., Jones, R., et al. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.657 · Cited by 40
Covell, D. G., Wallqvist, A., Huang, R., Thanki, N., Rabow, A. A., & Lu, X. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20392 · Cited by 43
A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and BeyondPreprint
Taldone, T., Wang, T., Rodina, A., Pillarsetty, N., Digwal, C. S., Sharma, S., Yan, P., Joshi, S., Pagare, P. P., Bolaender, A., et al. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034116 · Cited by 40
Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors
Chen, D., Shen, A., Li, J., Shi, F., Chen, W., Ren, J., Liu, H., Xu, Y., Wang, X., Yang, X., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.065 · Cited by 39
Identification of Diverse Microbial Metabolites as Potent Inhibitors of HIV-1 Tat Transactivation
Jayasuriya, H., Zink, D. L., Polishook, J. D., Bills, G. F., Dombrowski, A. W., Genilloud, O., Peláez, F., Herranz, L., Quamina, D. S., Lingham, R. B., et al. (2005) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490162 · Cited by 39
Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol
Corbett, K. D., & Berger, J. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl567 · Cited by 39
Reaction-Driven De Novo Design, Synthesis and Testing of Potential Type II Kinase Inhibitors
Schneider, G., Geppert, T., Hartenfeller, M., Reisen, F., Klenner, A., Reutlinger, M., Hähnke, V. D., Hiss, J. A., Zettl, H., Keppner, S., et al. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.8 · Cited by 39
Oxidative Stress Plays a Critical Role in Inactivating Mutant BRAF by Geldanamycin Derivatives
Fukuyo, Y., Inoue, M., Nakajima, T., Higashikubo, R., Horikoshi, N. T., Hunt, C. R., Usheva, A., Freeman, M. L., & Horikoshi, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6602 · Cited by 39
Chemical-genetic approaches for exploring the mode of action of natural products
López, A., Parsons, A. B., Nislow, C., Giaever, G. N., & Boone, C. M. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8595-8_5 · Cited by 43
A methylated lysine is a switch point for conformational communication in the chaperone Hsp90
Rehn, A., Lawatscheck, J., Jokisch, M.-L., Mader, S. L., Luo, Q., Tippel, F., Blank, B., Richter, K., Lang, K., Kaila, V. R. I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15048-8 · Cited by 38
Sun, H.-P., Jia, J., Jiang, F., Xu, X., Liu, F., Guo, X., Cherfaoui, B., Huang, H., Pan, Y., & You, Q. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.061 · Cited by 38
Sano, M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00018-1 · Cited by 38
High-throughput screening for Hsp90 ATPase inhibitors
Avila, C., Hadden, M. K., Ma, Z., Kornilayev, B. A., Ye, Q.-Z., & Blagg, B. S. J. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.02.063 · Cited by 41
Chang, Y., Lee, L.-C., Sun, F., Chao, C., Fu, H., & Lai, Y. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20623 · Cited by 38
Wang, Y., Shen, H., Cheng, P., Chu, Y., Hwang, H.-R., Lam, K., & Lee, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155583 · Cited by 38
Selective Synthesis of the para-Quinone Region of Geldanamycin
Andrus, M. B., Hicken, E. J., Meredith, E. L., Simmons, B. L., & Cannon, J. F. (2003) · Organic Letters · doi:10.1021/ol035400g · Cited by 38
The Molecular Chaperone Hsp90 Mediates Heme Activation of the Yeast Transcriptional Activator Hap1
Lee, H. C., Hon, T., & Zhang, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106951200 · Cited by 38
Goode, K. M., Petrov, D. P., Vickman, R. E., Crist, S. A., Pascuzzi, P. E., Ratliff, T., Davisson, V. J., & Hazbun, T. R. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.05.006 · Cited by 37
Isobaric Quantitative Protein Interaction Reporter Technology for Comparative Interactome Studies
Chavez, J. D., Keller, A., Mohr, J. P., & Bruce, J. E. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03128 · Cited by 38
Blum, G., Kainzner, B., Grif, K., Dietrich, H., Zeiger, B., Sonnweber, T., & Lass‐Flörl, C. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03848.x · Cited by 37
F1F0-ATP synthase functions as a co-chaperone of Hsp90–substrate protein complexes
Papathanassiu, A. E., MacDonald, N. J., Bencsura, Á., & Vu, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.104 · Cited by 37
Zhao, Q., Zhu, H.-P., Xie, X., Mao, Q., Liu, Y., He, X., Peng, C. Y., Jiang, Q., & Huang, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051845 · Cited by 37
Yin, X., Zhang, H., Burrows, F. J., Zhang, L., & Shores, C. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2272 · Cited by 37
Targeting Hsp90 in urothelial carcinoma
Chehab, M., Caza, T. N., Skotnicki, K., LANDAS, S. K., Bratslavsky, G., Mollapour, M., & Bourboulia, D. (2015) · Oncotarget · doi:10.18632/oncotarget.3502 · Cited by 40
Recent update on discovery and development of Hsp90 inhibitors as senolytic agents
Gupta, S. D., & Pan, C. H. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.115 · Cited by 38
Hsp90 is involved in the formation of P-bodies and stress granules
Matsumoto, K., Minami, M., Shinozaki, F., Suzuki, Y., Abe, K., Zenno, S., Matsumoto, S., & Minami, Y. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.088 · Cited by 36
Development and optimization of a useful assay for determining Hsp90’s inherent ATPase activity
Avila, C., Kornilayev, B. A., & Blagg, B. S. J. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.09.027 · Cited by 42
Besant, P. G., Lasker, M. V., Bui, C. D., & Turck, C. W. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.289 · Cited by 36
Millson, S. H., Chua, C., Roe, S. M., Polier, S., Solovieva, S. E., Pearl, L. H., Sim, T., Prodromou, C., & Piper, P. W. (2011) · The FASEB Journal · doi:10.1096/fj.11-188821 · Cited by 37
Self-citationLazenby, M., Hills, R. K., Burnett, A. K., & Zabkiewicz, J. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.03.016 · Cited by 36
Targeting the Hsp90 Chaperone: Synthesis of Novel Resorcylic Acid Macrolactone Inhibitors of Hsp90
Day, J. E. H., Sharp, S. Y., Rowlands, M., Aherne, W., Workman, P., & Moody, C. J. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200902766 · Cited by 36
The E3 Ligase CHIP Mediates Ubiquitination and Degradation of Mixed-Lineage Kinase 3
Blessing, N. A., Brockman, A. L., & Chadee, D. N. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00296-14 · Cited by 36
Na, Y. J., Jeon, Y. J., Suh, J., Kang, J. S., Yang, K., & Kim, H. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00113-8 · Cited by 36
Incapacitating the evolutionary capacitor: Hsp90 modulation of disease
Yeyati, P. L., & van Heyningen, V. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.004 · Cited by 35
Roe, S. M., Wahab, B., Török, Z., Horváth, I., Vígh, L., & Prodromou, C. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00051 · Cited by 36
Self-citationNatural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors
Musso, L., Dallavalle, S., Merlini, L., Bava, A., Nasini, G., Penco, S., Giannini, G., Giommarelli, C., Cesare, M. D., Zuco, V., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.068 · Cited by 35
Radanamycin, a macrocyclic chimera of radicicol and geldanamycin
Wang, M., Shen, G., & Blagg, B. S. J. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.01.086 · Cited by 35
Identification of novel quaternary domain interactions in the Hsp90 chaperone, GRP94
Chu, F., Maynard, J. C., Chiosis, G., Nicchitta, C. V., & Burlingame, A. L. (2006) · Protein Science · doi:10.1110/ps.052065106 · Cited by 34
Lee, Y. S., Marcu, M. G., & Neckers, L. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.05.010 · Cited by 35
Coumarin Derivatives as Anticancer Agents: Mechanistic Landscape with an Emphasis on Breast Cancer
Hacholli, V. B., Shubha, M. R., Prabhanajan, B. H., Lavanya, M., Pramod, S., Kumar, A., Szeleszczuk, Ł., & Gackowski, M. (2025) · Molecules · doi:10.3390/molecules30214167 · Cited by 37
Mehta, P. P., Whalen, P. M., Baxi, S. M., Kung, P., Yamazaki, S., & Yin, M.-J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0592 · Cited by 34
RetractedLauria, A., Ippolito, M., & Almerico, A. M. (2009) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2009.07.010 · Cited by 34
Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells
Marcus, E. A., Tokhtaeva, E., Тurdikulova, S., Capri, J. R., Whitelegge, J. P., Scott, D. R., Sachs, G. M., Berditchevski, F., & Vagin, O. (2016) · Biochemical Journal · doi:10.1042/bcj20160203 · Cited by 34
Natural Product Chemistry and Cancer Drug Discovery
Huryn, D. M., & Wipf, P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00003-6 · Cited by 39
Signaling cascades as drug targets in model and pathogenic fungi.
Bastidas, R. J., Reedy, J. L., Morales-Johansson, H., Heitman, J., & Cardenas, M. E. (2008) · PubMed · Cited by 46
Shi, L., Zhang, Z., Fang, S., Xu, J., Liu, J., Shen, J., Fang, F., Luo, L., & Yin, Z. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.019 · Cited by 34
Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies
Beck, R., Dejeans, N., Glorieux, C., Pedrosa, R. C., Vásquez, D., Valderrama, J. A., Calderón, P. B., & Verrax, J. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796011256 · Cited by 34
Workman, P. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.020 · Cited by 40
Picard, D., Suslova, E., & Briand, P.-A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.08.026 · Cited by 33
Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold
Strocchia, M., Terracciano, S., Chini, M. G., Vassallo, A., Vaccaro, M. C., Piaz, F. D., Leone, A., Riccio, R., Bruno, I., & Bifulco, G. (2015) · Chemical Communications · doi:10.1039/c4cc10074c · Cited by 33
The epigenetic regulator Smchd1 contains a functional GHKL-type ATPase domain
Chen, K., Dobson, R. C. J., Lucet, I. S., Young, S. N., Pearce, F. G., Blewitt, M. E., & Murphy, J. M. (2016) · Biochemical Journal · doi:10.1042/bcj20160189 · Cited by 34
Overview of host-directed antiviral targets for future research and drug development
Gu, X., Zheng, M., Gao, Y. M., Lin, S. J., Zhang, X., Chen, C., Zhu, H., Sun, W., & Zhang, Y. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.011 · Cited by 35
Kashif, M., Andersson, C. R., Hassan, S., Karlsson, H., Senkowski, W., Fryknäs, M., Nygren, P., Larsson, R. L., & Gustafsson, M. G. (2015) · Scientific Reports · doi:10.1038/srep14118 · Cited by 35
Mahankali, B., & Pabbaraja, S. (2015) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201500395 · Cited by 32
Cho, J. Y., & Park, J. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9112217 · Cited by 35
Management of Hsp90-Dependent Protein Folding by Small Molecules Targeting the Aha1 Co-Chaperone
Singh, J. K., Hutt, D. M., Tait, B. D., Guy, N. C., Sivils, J. C., Ortiz, N. R., Payan, A. N., Komaragiri, S. K., Owens, J. J., Culbertson, D. S., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.01.008 · Cited by 33
Stofberg, M. L., Caillet, C., de Villiers, M., & Zininga, T. (2021) · Cells · doi:10.3390/cells10112849 · Cited by 34
Ayrault, O., Godeny, M. D., Dillon, C. P., Zindy, F., Fitzgerald, P., Roussel, M. F., & Beere, H. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902880106 · Cited by 33
High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors
Davenport, J., Balch, M., Galam, L., Girgis, A., Hall, J., Blagg, B. S. J., & Matts, R. L. (2014) · Biology · doi:10.3390/biology3010101 · Cited by 35
Iwai, C., Li, P., Kurata, Y., Hoshikawa, Y., Morikawa, K., Maharani, N., Higaki, K., Sasano, T., Notsu, T., Ishido, Y., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt200 · Cited by 32
Bekker, G., Araki, M., Oshima, K., Okuno, Y., & Kamiya, N. (2020) · Journal of Computational Chemistry · doi:10.1002/jcc.26203 · Cited by 32
Discovery and development of purine-scaffold Hsp90 inhibitors
Chiosis, G., Kang, Y., & Sun, W. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.1.99 · Cited by 33
Forskolin increases neuregulin receptors in human Schwann cells without increasing receptor mRNA
Fregien, N. L., White, L. A., Bunge, M. B., & Wood, P. M. (2004) · Glia · doi:10.1002/glia.20091 · Cited by 32
Synthesis of the Left-Hand Portion of Geldanamycin Using an Anti Glycolate Aldol Reaction
Andrus, M. B., Meredith, E. L., & Sekhar, B. B. V. S. (2000) · Organic Letters · doi:10.1021/ol0068997 · Cited by 32
HSP90 and its inhibitors (Review)
Naomoto (2010) · Oncology Reports · doi:10.3892/or_00000787 · Cited by 31
Inside the Hsp90 inhibitors binding mode through induced fit docking
Lauria, A., Ippolito, M., & Almerico, A. M. (2008) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2008.11.004 · Cited by 31
Rowlands, M., McAndrew, C., Prodromou, C., Pearl, L. H., Kalusa, A., Jones, K., Workman, P., & Aherne, W. (2010) · SLAS DISCOVERY · doi:10.1177/1087057109360253 · Cited by 37
Self-citationErnst, K., Schnell, L., & Barth, H. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_14 · Cited by 38
HECTD3 Mediates an HSP90-Dependent Degradation Pathway for Protein Kinase Clients
Li, Z., Zhou, L., Prodromou, C., Savic, V., & Pearl, L. H. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.078 · Cited by 35
Self-citationMikołajczyk, M., & Nelson, M. A. (2004) · Biochemical Journal · doi:10.1042/bj20040848 · Cited by 40
Aschner, J. L., Foster, S. L., Kaplowitz, M. R., Zhang, Y.-M., Zeng, H., & Fike, C. D. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2006 · Cited by 31
Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications
Ardestani, M., Khorsandi, Z., Keshavarzipour, F., Iravani, S., Sadeghi‐Aliabadi, H., & Varma, R. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102220 · Cited by 30
Llewellyn, J., Mallikarjun, V., Appleton, E., Osipova, M., Gilbert, H. T. J., Richardson, S. M., Hubbard, S. J., & Swift, J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210745120 · Cited by 33
Lalo, U., Jones, S., Roberts, J. A., Mahaut‐Smith, M. P., & Evans, R. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.376566 · Cited by 30
Inhibition of Ca2+-Signal-Dependent Growth Regulation by Radicicol in Budding Yeast
Chanklan, R., AIHARA, E., Koga, S., Takahashi, H., Mizunuma, M., & Miyakawa, T. (2008) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70502 · Cited by 30
Metadata
- Authors
- Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H.
- Affiliations
- University College London (GB)
- Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, U.K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-01-01
- Volume
- 42
- Issue
- 2
- Pages
- 260-266
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2042699875
- Cited by
- 1,004
- References
- 26
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 25 · 2023: 17 · 2022: 24 · 2021: 23 · 2020: 38 · 2019: 45 · 2018: 32 · 2017: 23 · 2016: 35 · 2015: 43 · 2014: 47 · 2013: 31 · 2012: 50
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- HSP90, molecular chaperones, geldanamycin, radicicol, antitumor antibiotics, ATPase inhibition, protein folding
- MeSH terms
- Adenosine Diphosphate, Adenosine Triphosphatases, Antibiotics, Antineoplastic, Calorimetry, Lactones, Models, Molecular, Quinones, Structure-Activity Relationship, Benzoquinones, Crystallography, X-Ray, Molecular Mimicry, HSP90 Heat-Shock Proteins, Macrolides, Lactams, Macrocyclic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.